Caribou Biosciences, Inc. — Form D/A

Caribou Biosciences, Inc. of BERKELEY, CA, a company, filed a Form D amendment with the SEC on 2015-03-24. The offering totals $11.5M, of which $11.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Rodolphe BarrangouDirectorLONG ISLAND CITY, NY
Rachel HaurwitzDirectorCAMBRIDGE, MA
Jenny RookeDirectorWaltham, MA
Robert WeisskoffDirectorFoster City, CA
Rachel HaurwitzExecutive OfficerCAMBRIDGE, MA
Andrew MayExecutive OfficerAltrincham, X0
Robert E WeisskoffDirectorBerkeley, CA
Steven B KannerExecutive OfficerBerkeley, CA
Natalie R SacksDirectorBerkeley, CA
Santhosh G PalaniDirectorBerkeley, CA
Jeffrey G Long-McGieDirectorBerkeley, CA
Rachel E HaurwitzDirectorBerkeley, CA
Rachel E HaurwitzExecutive OfficerBerkeley, CA
Jason B O'ByrneExecutive OfficerBerkeley, CA
Barbara G McClungExecutive OfficerBerkeley, CA
Jenny E RookeDirectorBerkeley, CA
Rodolphe E BarrangouDirectorBerkeley, CA
Andrew P MayExecutive OfficerBerkeley, CA
Un G Kwon-CasadoExecutive OfficerBerkeley, CA
Philip E AustinDirectorBerkeley, CA

Other filings by this issuer (3)

FiledFormOfferingSold
2021-03-05D$115.0M$115.0M
2016-05-25D$30.1M$14.5M
2014-09-23D$5.2M$2.9M

More